U

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

Field Reimbursement Manager

Biology & BiotechConfirmed live in the last 24 hours
Full-timeGeorgia, USANo salary listed

About the Job

Requirements

  • A bachelor's degree in a related field is required.
  • At least 4 years of pharmaceutical, biotech, or medical device experience is required.
  • At least 2 years of reimbursement experience is required.
  • Strong written, verbal, and interpersonal communication skills are required.
  • Ability to communicate cross-functionally and within the region to share results, assist with training, and develop best practices.
  • Ability to travel, including overnight stays, is required.
  • A valid driver's license is required.

Responsibilities

  • Ensure target accounts understand all applicable billing and coding requirements associated with UroGen products.
  • Develop and leverage relationships with key customers in the target geography.
  • Understand billing and coding responsibilities within target accounts, including urology clinics, ambulatory surgery centers, and hospitals.
  • Answer reimbursement questions for each account.
  • Understand applicable reimbursement regulations for Medicaid, Medicare, and commercial payers.
  • Partner effectively with other account-team members to achieve the best possible outcome for the patient and the account.
  • Translate strategies into actionable plans for each account.
  • Demonstrate expertise in the disease state, product, surgical process, and reimbursement process.
  • Organize and complete administrative responsibilities efficiently and on time, including call reporting, expense reporting, communication, and account documentation.
  • Understand opportunities unique to the geography.

Desired Qualifications

  • At least 2 years of hospital or large-account experience is preferred.
  • At least 2 years of urology experience is preferred.

About the Company

UroGen Pharma, Inc

Develops RTGel-based drug delivery for uro-oncology

UroGen Pharma develops RTGel-based drug-delivery therapies for urothelial and specialty cancers, commercializing products like Jelmyto and ZUSDURI and advancing a pipeline that includes UGN-102, UGN-103, UGN-104, and UGN-301. Its RTGel platform is liquid at cool temperatures and gels at body temperature, allowing chemotherapy to stay at the treatment site longer for local, sustained exposure. The company differentiates itself by delivering established chemotherapy directly to the disease site to reduce systemic exposure and by building a multi-product portfolio focused on urothelial cancers. Its goal is to improve local treatment outcomes and grow a diversified, globally commercial portfolio through ongoing clinical development and partnerships.

Company size
201-500
Company stage
IPO
Headquarters
Princeton, NJ
Founded
2004

Recently Posted Jobs

Explore more opportunities at UroGen Pharma, Inc

See more jobs